• "Whatever is bad goes back to the woman": The gendered blame game of sickle cell disease in Malawi and Uganda
• A case report on congenital hypothyroidism and alpha thalassemia in children with anemia and muscle damage as the main manifestation
• A Cure for Sickle Cell Disease
• A high stable sample loading for analysis of adult alpha-thalassemia via the improved microarray isoelectric focusing of Hb species
• A multiplexed, allele-specific recombinase polymerase amplification assay with lateral flow readout for sickle cell disease detection
• A novel variant in the SPTB gene underlying hereditary spherocytosis and a literature review of previous variants
• Acute chest syndrome in sickle cell disease
• Addressing the Thalassemia Burden in Pakistan: The urgent need for a mandate on premarital screening
• Advances in Hemoglobinopathies and Thalassemia Evaluation
• Advances in pharmacotherapy for sickle cell disease: what is the current state of play?
• Allogeneic Hematopoietic Stem Cell Transplantation-Induced Anaphylaxis in 2 Pediatric Cases
• Anemia and iron overload as prognostic markers of outcomes in beta-thalassemia
• Applications of Flow Cytometry in Diagnosis and Evaluation of Red Blood Cell Disorders
• Appropriateness of the EQ-5D-5L in capturing health-related quality of life in individuals with transfusion-dependent β-thalassemia: a mixed methods study
• Assessing multilevel barriers to hydroxyurea adherence in youth with sickle cell disease using pharmacy-based refill records
• Assessing Psychosocial Risk and Resilience to Support Readiness for Gene Therapy in Sickle Cell Disease: A Consensus Statement
• Association between fetal hemoglobin, lactate dehydrogenase, and disease severity in patients with sickle cell disease at Bugando Medical Centre, Mwanza, Tanzania
• Budget Impact of Disease-Modifying Treatments and a CRISPR Gene-Edited Therapy for Sickle Cell Disease
• Carrier screening for 223 monogenic diseases in Chinese population: a multi-center study in 33 104 individuals
• Case report: Persistent hypogammaglobulinemia and mixed chimerism after HLA class-II disparate-hematopoietic stem cell transplant
• Cell and gene therapy accessibility
• Chronic automated red cell exchange therapy for sickle cell disease
• Clinical and genetic characteristics of Chinese pediatric and adult patients with hereditary spherocytosis
• Clinical efficacy of thalidomide for various genotypes of beta thalassemia
• Clinical, aetiological and therapeutic features of severe sickle cell related vaso-occlusive crisis at the Sylvanus Olympio University Hospital, Lomé
• Comorbidities and complications in adult and paediatric patients with pyruvate kinase deficiency: Analysis from the Peak Registry
• Concomitant sickle cell disease and systemic lupus erythematosus: A single-center case series
• Contextual factors and G6PD diagnostic testing: a scoping review and evidence and gap map
• CRISPR/Cas12a-triggered ordered concatemeric DNA probes signal-on/off multifunctional analytical sensing system for ultrasensitive detection of thalassemia
• Cross-sectional study on the impact of cardiac and hepatic iron overload, as measured by MRI T2*, on the quality of life in children with severe beta-thalassemia major
• Designing a single-arm phase 2 clinical trial of mitapivat for adult patients with erythrocyte membranopathies (SATISFY): a framework for interventional trials in rare anaemias - pilot study protocol
• Eliminating Health Care Access and Quality Inequities in Sickle Cell Disease: Policy Lessons from the End Sepsis Initiative
• Emergency department 30-Day emergency department revisits among people with sickle cell disease: Variations in characteristics
• Emergency department management of patients with sickle cell disease
• Emergency department utilization before and during the COVID-19 pandemic among individuals with sickle cell disease
• EPCR shedding light on sickle nephropathy
• Erythroid Krüppel-Like Factor (KLF1): A Surprisingly Versatile Regulator of Erythroid Differentiation
• Evaluation of a point-of-care rapid diagnostic test kit (SICKLECHECK) for screening of sickle cell diseases
• Examining community-level social vulnerability and emergency department use for people living with sickle cell disease in Michigan
• Exploring the bone marrow micro environment in thalassemia patients: potential therapeutic alternatives
• Exploring the genetic mechanisms: SELP gene's contribution to alleviating vaso-occlusive crisis in sickle cell disease
• Flow Cytometry as a New Accessible Method to Evaluate Diagnostic Osmotic Changes in Patients with Red Blood Cell Membrane Defects
• From Alpha-Thalassemia Trait to <em>NPRL3</em>-Related Epilepsy: A Genomic Diagnostic Odyssey
• G6PD deficiency and diabetes complications
• G6PD deficiency mediated impairment of iNOS and lysosomal acidification affecting phagocytotic clearance in microglia in response to SARS-CoV-2
• Gene therapies on the horizon for sickle cell disease: a clinician's perspective
• Genome editing in K562 cells suggests a functional role for the XmnI Gg polymorphism: a widely used genetic marker in β-thalassemia and sickle cell disease patients
• Genome-wide methylation and gene-expression analyses in thalassemia
• Global, regional, and national burden of thalassemia during 1990-2019: A systematic analysis of the Global Burden of Disease Study 2019
• Glucose-6-phosphate dehydrogenase deficiency as a cause for nonimmune hydrops fetalis and severe fetal anemia: A systematic review
• Health Supervision for Children and Adolescents With Sickle Cell Disease: Clinical Report
• Hydroxyurea achieved a hematologic response in a patient with β-thalassemia and secondary severe thrombocytosis post splenectomy
• Implementation of Universal Screening for G6PD Deficiency in Newborns
• Inflammatory turmoil within: an exploration of autoinflammatory disease genetic underpinnings, clinical presentations, and therapeutic approaches
• Informing parents of newborns with sickle cell trait detected at neonatal screening: A northern France experience
• Iron scavenging and myeloid cell polarization
• Limited access to transcranial Doppler screening and stroke prevention for children with sickle cell disease in Europe: Results of a multinational EuroBloodNet survey
• Luspatercept for non-deletional hemoglobin H disease
• Measurement of left atrial size as a predictor of severity of illness in sickle cell disease
• Medicaid Coverage in Early Childhood for Children With Sickle Cell Disease
• Neuromuscular dysfunction and pathogenesis in triosephosphate isomerase deficiency
• New WHO classification of genetic variants causing G6PD deficiency
• Noninvasive Prenatal Genetic Screening of Cell-Free Fetal DNA for Early Prediction of β-Thalassemia Using Fiber Optic Nanogold-Linked Sorbent Assay
• People with sickle cell disease face damaging stigma
• Perinatal risk factors and neurocognitive outcomes in children and adolescents with sickle cell disease
• PGC-1α agonism induces fetal hemoglobin and exerts antisickling effects in sickle cell disease
• Post-GWAS Validation of Target Genes Associated with HbF and HbA₂ Levels
• Prediction of Functional Academic Outcomes by Fine Motor Skills in Individuals With Sickle Cell Disease
• Presentation of Acute Pancreatitis in Sickle Cell Disease Patients: A Single Hospital Experience
• Prevalence and risk factors predisposing low bone mineral density in patients with thalassemia
• Prevalence, Mortality, and Access to Care for Chronic Kidney Disease in Medicaid-Enrolled Adults With Sickle Cell Disease in California: Retrospective Cohort Study
• Prevalence, patterns, and factors associated with abnormal lung function among children with sickle cell disease in Uganda: a cross-sectional study
• Providing the Tools to Facilitate Quality Care for Children with Sickle Cell Disease
• Recent G6PD Screening Mandate: We Are Missing the Mark
• Recurrent haemorrhagic venous infarct in a patient with sickle cell disease
• Reproductive Health Assessment and Reports of Fertility Counseling in Pediatric and Adolescent Patients with Sickle Cell Disease After Hematopoietic Cell Transplantation
• Seroprevalence of SARS-CoV-2 in pediatric hematology-oncology patients
• Serum microRNAs as new biomarkers for detecting subclinical hemolysis in the nonacute phase of G6PD deficiency
• Serum visfatin level in β-thalassemia and its correlation with disease severity
• Sexually transmitted infection testing and diagnosis in adolescents and young adults with sickle cell disease
• Sickle cell disease - common and dangerous complications
• Sickle Cell Disease and Gut Health: The Influence of Intestinal Parasites and the Microbiome on Angolan Children
• Splenic complications in pediatric sickle cell disease: A retrospective cohort review
• Studies of Exagamglogene Autotemcel - Age and Place
• Studies of Exagamglogene Autotemcel - Age and Place. Reply
• SURGICAL OUTCOMES IN CONCURRENT SICKLE CELL AND DIABETIC RETINOPATHY
• SURGICAL OUTCOMES OF RETINAL DETACHMENT ASSOCIATED WITH PROLIFERATIVE SICKLE CELL RETINOPATHY
• Thalassaemia: NICE recommends "life changing" gene editing therapy
• The effect of single low-dose primaquine treatment for uncomplicated Plasmodium falciparum malaria on haemoglobin levels in Ethiopia: a longitudinal cohort study
• The medication usage pattern and prevalence of polypharmacy among patients with sickle cell disease: a population-based study in southern Iran
• The Ugandan sickle Pan-African research consortium registry: design, development, and lessons
• The Wolf in Sheep's Clothing Leishmania tropica: Two Pediatric Visceral Cases
• Towards genomic medicine: a tailored next-generation sequencing panel for hydroxyurea pharmacogenomics in Tanzania
• Transcriptional Repressor BCL11A in Erythroid Cells
• Treatment of Tuberculous Pleurisy With Contezolid in a Child With Glucose-6-Phosphate Dehydrogenase Deficiency: The First Case Report
• Type 2 Diabetes in Patients with G6PD Deficiency
• Unpacking the utility of euvolemic automated transfusion in sickle cell disease
• Update on SickleInAfrica: a collaborative and multidimensional approach to conduct research and improve health
• Updates in Pediatric Sickle Cell Lung Disease
• What is the future of digital tools to help manage pain in sickle cell disease patients?